Dyspnea can have a debilitating effect on psychosocial and physical fu
nctioning in patients with chronic obstructive airways disease, Previo
us research was suggested that treatment of concomitant mood or anxiet
y symptoms can improve dyspnea and exercise intolerance among patients
with respiratory disease. The authors report here on a case series of
7 patients with obstructive airways disease who reported improvements
in dyspnea after sertraline 25-100 mg/day was added to their medicati
on regimens. Four of the seven patients did not appear to meet syndrom
al criteria for a mood or anxiety disorder Subjective improvements in
dyspnea may have been related to relief of mood or anxiety symptoms or
to direct effects on central respiratory systems. Controlled studies
are needed to clarify the potential antidyspneic effects of sertaline.